Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Cassava Sciences Inc (NASDAQ: SAVA) closed at $3.42 down -4.47% from its previous closing price of $3.58. In other words, the price has decreased by -$4.47 from its previous closing price. On the day, 1.57 million shares were traded. SAVA stock price reached its highest trading level at $3.56 during the session, while it also had its lowest trading level at $3.35.
Ratios:
For a deeper understanding of Cassava Sciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.43 and its Current Ratio is at 2.43. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 08, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $116.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 30 ’25 when Cook Robert Christopher bought 13,725 shares for $2.91 per share. The transaction valued at 39,940 led to the insider holds 13,725 shares of the business.
Barry Richard bought 7,172 shares of SAVA for $16,352 on Sep 22 ’25. The President & CEO now owns 714,675 shares after completing the transaction at $2.28 per share. On Sep 18 ’25, another insider, Barry Richard, who serves as the President & CEO of the company, bought 190,633 shares for $2.24 each. As a result, the insider paid 426,424 and bolstered with 660,195 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SAVA now has a Market Capitalization of 165213008 and an Enterprise Value of 52832004.
Stock Price History:
The Beta on a monthly basis for SAVA is -1.08, which has changed by -0.8674932 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, SAVA has reached a high of $33.98, while it has fallen to a 52-week low of $1.15. The 50-Day Moving Average of the stock is 13.22%, while the 200-Day Moving Average is calculated to be 45.33%.
Shares Statistics:
For the past three months, SAVA has traded an average of 2.54M shares per day and 2178650 over the past ten days. A total of 48.31M shares are outstanding, with a floating share count of 41.72M. Insiders hold about 13.64% of the company’s shares, while institutions hold 25.36% stake in the company. Shares short for SAVA as of 1760486400 were 6843885 with a Short Ratio of 2.70, compared to 1757894400 on 5889700. Therefore, it implies a Short% of Shares Outstanding of 6843885 and a Short% of Float of 14.32.
Earnings Estimates
The dynamic stock of Cassava Sciences Inc (SAVA) is currently being evaluated by a team of 1.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.27, with high estimates of -$0.27 and low estimates of -$0.27.
Analysts are recommending an EPS of between -$1.93 and -$1.93 for the fiscal current year, implying an average EPS of -$1.93. EPS for the following year is -$1.16, with 1.0 analysts recommending between -$1.16 and -$1.16.
